PATENT CLAIM ANALYSIS

Application Number: 16319808
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["424", "001890"]

Abstract:
The present invention relates to novel compounds of the formula (I) that can be employed in the selective Tau detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease and other tauopathies using Positron Emission Tomography (PET) Imaging.

Claim (Index 35):
The method of  claim 34 , wherein the tauopathy is a 3R tauopathy or a 4R tauopathy.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 1.14634
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15112672', '14740595', '14486040', '15324141', '15750982']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.743614501531817
- 35 USC 102 Novelty (BERT): 0.5485805306504165
- Combined Prediction Score: 0.724111104443677
- Mean Citation Score: 325.844132
- Max Citation Score: 440.98587
- Similarity Product: 258.3091747154313

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test